Advancements in NSCLC Profiling and Understanding Immunotherapy Resistance

Experts examine primary and acquired resistance mechanisms in immunotherapy, while promoting realistic treatment strategies.

Related Keywords

,Precision Medicine ,Bridging Gaps ,Patients Without Driver Mutations ,Pd L1 ,High Tumor Volume ,Chemotherapy ,Crisis Of Disease ,Burden Of Disease ,Platinum Doublet ,Driver Population ,Pd L1 Negative ,Immune Suppressive Microenvironment ,Poseidon Trial ,Ctla 4 Inhibitor ,Mechanisms Of Resistance ,